Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Nephrology, Dialysis and Transplantation

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/NDT/16.1.193PMID 11209032
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Combination of interferon alpha and ribavirin in the treatment of hepatitis C: implications for the clinical nephrologist.

  1999cited by this paper
• The clinical pharmacology of ribavirin.

  1999cited by this paper
• Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions.

  1998cited by this paper
• Interferon Therapy for Chronic Hepatitis C in Hemodialysis Patients: Increased Serum Levels of Interferon

  1998cited by this paper
• Ribavirin, a broad spectrum antiviral agent

  1980cited by this paper

• M anagement of HCV infection in chronic kidney disease

  2022cites this paper
• 1 Infectious Complications in Kidney Transplantation

  2019cites this paper
• Management of chronic hepatitis C virus infection in patients with end-stage renal disease: a review

  2015cites this paper
• [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].

  2015cites this paper
• [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].

  2015cites this paper
• Hepatitis C infection in hemodialysis patients: A review.

  2015cites this paper
• Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015.

  2015cites this paper
• HIV and HCV Medications in End‐Stage Renal Disease

  2015cites this paper
• Factors associated with efficacy of pegylated interferon-α plus ribavirin for chronic hepatitis C after renal transplantation.

  2014cites this paper
• Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India.

  2014cites this paper
• Latin American Association for the Study of the Liver recommendations on treatment of hepatitis C.

  2014cites this paper
• Acute rejection of non-functional renal grafts in dialysis patients after starting treatment with interferon and ribavirin.

  2014cites this paper
• Ribavirin at the Era of Novel Direct Antiviral Agents for the Treatment of Hepatitis C Virus Infection: Relevance of Pharmacological Monitoring

  2014cites this paper
• Antiviral therapy (pegylated interferon and ribavirin) of hepatitis C in dialysis patients: meta‐analysis of clinical studies

  2014cites this paper
• Viral Hepatitis in Solid Organ Transplantation

  2013cites this paper
• Hepatitis C virus infection in hemodialysis patients.

  2013cites this paper
• Hepatitis C infection and chronic renal diseases

  2013cites this paper
• Pharmacokinetics and safety of single-dose ribavirin in patients with chronic renal impairment.

  2013cites this paper
• Pegylated Interferon-α2a With or Without Low-Dose Ribavirin for Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Receiving Hemodialysis

  2013cites this paper
• Infección por el virus de la hepatitis C en pacientes con enfermedad renal crónica

  2013cites this paper
• Hepatitis C viral infection in patients with chronic kidney disease

  2012cites this paper
• Treatment of Hepatitis C in Solid Organ Transplantation

  2012cites this paper
• Pharmacokinetics, safety, and tolerability of ribavirin in hemodialysis-dependent patients

  2011cites this paper
• Combined antiviral therapy of hepatitis C virus in dialysis patients: meta‐analysis of clinical trials

  2011cites this paper
• Management of HCV infection in chronic kidney disease.

  2011cites this paper
• Anti‐viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy

  2011cites this paper
• Viral hepatitis in solid organ transplantation other than liver.

  2011cites this paper
• Infectious Complications in Kidney Transplantation

  2011cites this paper
• Viral hepatitis in renal transplantation.

  2011cites this paper
• Treatment of hepatitis C virus infection in patients with end‐stage renal disease

  2011cites this paper
• Ribavirin Combination Therapy of Chronic Hepatitis C Patients with End Stage Renal Disease: Review of Evidences on Efficacy and Safety

  2011cites this paper
• Should Ribavirin Be Used to Treat Hepatitis C in Dialysis Patients?

  2011cites this paper
• Hepatitis C and Kidney Transplantation

  2011cites this paper
• Treatment of Hepatitis C in Renal Transplantation Candidates: A Single-Center Experience

  2010cites this paper
• Management of Hepatitis C in Patients with End-stage Renal Disease

  2010cites this paper
• Hepatic disorders in chronic kidney disease

  2010cites this paper
• Viral Hepatitis in Solid Organ Transplant Recipients

  2009cites this paper
• Hepatitis C infection and chronic renal diseases.

  2009cites this paper
• Diagnosis, management, and treatment of hepatitis C: An update

  2009cites this paper
• Hepatitis C in Special Populations

  2009cites this paper
• Monotherapy with Pegylated Interferon Alpha‐2a in Hemodialyzed Patients with Chronic Hepatitis C

  2008cites this paper
• [Treatment of chronic hepatitis C virus infection in hemodialysis patients].

  2008cites this paper
• Pegylated interferon alpha-2a versus standard interferon alpha-2a for treatment-naive dialysis patients with chronic hepatitis C: a randomised study.

  2008cites this paper
• Management and treatment of hepatitis C: A review

  2008cites this paper
• Treatment of Dialysis Patients with Chronic Hepatitis C Using Pegylated Interferon and Low-Dose Ribavirin

  2008cites this paper
• HCV in Patients With End-Stage Renal Disease

  2008cites this paper
• The Management of Viral Hepatitis in CKD Patients: An Unresolved Problem

  2008cites this paper
• Chapter 30 – Liver Disease in Renal Transplant Recipients

  2008cites this paper
• New recommendations in the treatment of Gram-positive bacteraemia in dialysis patients.

  2008cites this paper
• Efficacy and safety of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C.

  2008cites this paper
• Treatment of chronic hepatitis C in hemodialysis patients

  2008cites this paper
• Therapeutic Aspects of Hepatitis C in Hemodialysis Patients

  2008cites this paper
• Hepatitis C virus infection in haemodialysis and kidney transplant patients

  2008cites this paper
• Hepatitis C Infection in Patients with Chronic Kidney Disease

  2008cites this paper
• Review Hepatitis C virus and kidney disease q

  2008cites this paper
• Viral Hepatitis in Elderly Haemodialysis Patients

  2008cites this paper
• Hepatitis C in Dialysed Patients – What Is the Current Optimal Treatment?

  2007cites this paper
• The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment.

  2007cites this paper
• Pegylated interferon alfa-2a (40 kD) and ribavirin in haemodialysis patients with chronic hepatitis C.

  2007cites this paper
• Treatment of HCV in patients with renal failure.

  2007cites this paper
• Pilot study of pegylated interferon‐alpha 2a in dialysis patients with chronic hepatitis C virus infection

  2007cites this paper
• Pegylated interferon α-2a versus standard interferon α-2a for treatment-naïve dialysis patients with chronic hepatitis C: a randomised study

  2007cites this paper
• Hepatitis C among Hemodialysis Patients: A Review on Epidemiologic, Diagnostic, and Therapeutic Features

  2007cites this paper
• Treatment of HCV infection in patients with renal failure

  2006cites this paper
• بررسی شیوع و عوامل خطرساز آلودگی به ویروس هپاتیت C در بیماران همو دیالیزی شهر قزوین در سال 1383

  2006cites this paper
• Lack of Efficacy of Pegylated Interferon Monotherapy for Hepatitis C in Patients With End-Stage Renal Disease on Dialysis.

  2006cites this paper
• Hepatitis C in transplant recipients of solid organs, other than liver.

  2006cites this paper
• Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant.

  2006cites this paper
• Efficacy and tolerability of pegylated‐interferon alpha‐2a in hemodialysis patients with chronic hepatitis C

  2006cites this paper
• Treatment of hepatitis C in special populations.

  2006cites this paper
• Efficacy and tolerance of interferon‐α in the treatment of chronic Hepatitis C in end‐stage renal disease patients on hemodialysis

  2006cites this paper
• Pegylated-interferon alpha 2a treatment for chronic hepatitis C in patients on chronic haemodialysis.

  2006cites this paper
• Factors accelerating liver fibrosis progression in renal transplant patients receiving ribavirin monotherapy for chronic hepatitis C

  2005cites this paper
• Hepatitis C virus infection: the new global epidemic

  2005cites this paper
• Diagnostic Accuracy of the Fibrotest in Hemodialysis and Renal Transplant Patients with Chronic Hepatitis C Virus

  2005cites this paper
• Tratamiento de hepatitis C en la insuficiencia renal crónica terminal en hemodiálisis con Interferón 2 b y ribavirina: A case report

  2005cites this paper
• Treatment of Chronic Hepatitis C in Patients with End-Stage Renal Disease and Hemophilia – The Singapore Experience

  2005cites this paper
• Applicability, Tolerability and Efficacy of Preemptive Antiviral Therapy in Hepatitis C‐Infected Patients Undergoing Liver Transplantation

  2005cites this paper
• Treatment of hepatitis C in special populations.

  2005cites this paper
• Treatment of hepatitis C in potential kidney and heart transplant patients.

  2005cites this paper
• Treatment of chronic hepatitis C infection in patients with renal failure.

  2005cites this paper
• Update on chronic hepatitis C.

  2005cites this paper
• Peginterferon and Dose-Titrated Ribavirin for Hepatitis C-Associated Nephrotic Membranoproliferative Glomerulonephritis Type 1

  2005cites this paper
• Kidney Transplantation in HIV‐Infected Patients

  2005cites this paper
• The role of hematopoietic growth factors in special populations with chronic hepatitis C: patients with HIV coinfection, end-stage renal disease, or liver transplantation.

  2004cites this paper
• Hepatitis C Infection Associated with Renal Disease and Chronic Renal Failure

  2004cites this paper
• Pegylated interferon‐alpha 2b monotherapy for haemodialysis patients with chronic hepatitis C

  2004cites this paper
• Treatment of chronic viral hepatitis in patients with renal disease.

  2004cites this paper
• Reply

  2004cites this paper
• Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.

  2004cites this paper
• Hepatitis C infection associated with renal disease and chronic renal failure.

  2004cites this paper
• The role of direct antiviral agents for the treatment of chronic hepatitis C in special populations

  2004cites this paper
• Diagnosis, management, and treatment of hepatitis C

  2004cites this paper
• Viral hepatitis in dialysis patients

  2004cites this paper
• Hepatitis C in chronic kidney disease and kidney transplantation : With special reference to epidemiology and treatment

  2003cites this paper
• Aasld Practice Guideline Diagnosis, Management, and Treatment of Hepatitis C

  2003cites this paper
• Meta‐analysis: interferon for the treatment of chronic hepatitis C in dialysis patients

  2003cites this paper
• Hepatitis C and renal disease: an update.

  2003cites this paper
• HCV infection and hemodialysis.

  2002cites this paper
• Single‐Dose Pharmacokinetics and Safety of Pegylated Interferon‐α2b in Patients with Chronic Renal Dysfunction

  2002cites this paper